Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) went down by -3.06% from its latest closing price when compared to the 1-year high value of $15.50 and move down -2483.33%, while TNXP stocks collected -4.91% of loss with the last five trading sessions. Press Release reported on 06/22/20 that Tonix Pharmaceuticals Announces Results from Preclinical Study of TNX-1700 Presented in a Poster at AACR Virtual Annual Meeting 2020

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Worth an Investment?

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) The 36 Months beta value for TNXP stocks is at 1.28, while of the analysts out of 0 who provided ratings for Tonix Pharmaceuticals Holding Corp. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $2.50 which is -$0.6 below current price. TNXP currently has a short float of 0.98% and public float of 52.28M with average trading volume of 6.78M shares.

TNXP Market Performance

TNXP stocks went down by -4.91% for the week, with the monthly drop of -12.84% and a quarterly performance of -19.43%, while its annual performance rate touched -95.62%. The simple moving average for the period of the last 20 days is -8.62% for TNXP stocks with the simple moving average of -64.64% for the last 200 days.

Analysts’ Opinion on Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Many brokerage firms have already submitted their reports for TNXP stocks, with ROTH Capital repeating the rating for TNXP shares by setting it to “Buy”. The predicted price for TNXP socks in the upcoming period according to ROTH Capital is $4 based on the research report published on April 18, 2019.

ROTH Capital, on the other hand, stated in their research note that they expect to see TNXP stock at the price of $6. The rating they have provided for TNXP stocks is “Buy” according to the report published on August 18, 2017.

ROTH Capital gave “ Neutral” rating to TNXP stocks, setting the target price at $6 in the report published on September 7, 2016.

TNXP Stocks -13.63% Far from 50 Day Moving Average

After a stumble in the market that brought TNXP to its low price for the period of the last 52 weeks, Tonix Pharmaceuticals Holding Corp. was unable to take a rebound, for now settling with -96.15% of loss for the given period.

The stock volatility was left at 9.19%, however, within the period of a single month, the volatility rate increased by 7.04%, while the shares sank at the distance of -9.60% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -25.43% lower at the present time.

In the course of the last 5 trading sessions, TNXP went down by -4.91%, which changed the moving average for the period of 200 days to the total of -88.53% of losses for the stock in comparison to the 20-day moving average settled at $0.6493. In addition, Tonix Pharmaceuticals Holding Corp. saw -49.04% in overturn over the period of a single year with a tendency to cut further losses.

TNXP Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Tonix Pharmaceuticals Holding Corp. (TNXP), starting from LEDERMAN SETH, who bought 20,000 shares at the price of $1.16 back on Dec 03. After this action, Rushing now owns 23,267 shares of Tonix Pharmaceuticals Holding Corp., valued at $23,180 with the latest closing price.

TNXP Stock Fundamentals

Based on Tonix Pharmaceuticals Holding Corp. (TNXP), the company’s capital structure generated 3.80 points for debt to equity in total, while total debt to capital is set at the value of 3.66.